CompletedPhase 4NCT02703194

Leflunomide for Maintenance of Remission in IgG4 Related Disease

Studying IgG4-related disease

Last synced from ClinicalTrials.gov

Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing data

Key facts

Sponsor
Chinese PLA General Hospital
Principal Investigator
Jian Zhu
Chinese PLA General Hospital
Intervention
Prednisone(drug)
Enrollment
68 enrolled
Eligibility
18-80 years · All sexes
Timeline
20162019

Study locations (1)

Primary source

Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.

Open NCT02703194 on ClinicalTrials.gov

Other trials for IgG4-related disease

Additional recruiting or active studies for the same condition.

See all trials for IgG4-related disease

← Back to all trials